New study aims to uncover hidden muscle weakness in early lung disease

NCT ID NCT07249567

First seen Jan 05, 2026

Summary

This study compares muscle strength, exercise ability, and oxygen use in 60 people with COPD, a condition called PRISm (which is like early-stage COPD), and healthy volunteers. Researchers will measure breathing muscle strength, arm and leg strength, and how well muscles use oxygen during exercise. The goal is to understand how PRISm affects the body compared to COPD and normal aging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karabuk University, Physiotherapy and Rehabilitation Application and Research Center

    RECRUITING

    Karabük, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand and manage breathing and muscle problems in people with early-stage lung conditions like PRISm.

What could go wrong

This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health outcomes.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.